Transformative Treatments 2023 IHH Healthcare Singapore • CAR T-cell therapy: Groundbreaking immunotherapy that reprogrammes a patient’s immune cells to recognise and attack cancer cells. It offers hope to patients with certain types of leukemia and lymphoma that have been resistant to other treatments. • da Vinci Robotic Surgical System: Surgical system that allows surgeons to perform minimally invasive procedures with greater precision and control. Patients benefit from smaller incisions, reduced pain, shorter hospital stays, and faster recovery. This reflects IHH’s expertise in minimally invasive surgery and its ability to offer superior outcomes for patients, available at Gleneagles Hospital Singapore. Acibadem (Türkiye) • In-Vitro Fertilisation (IVF): Some 2,200 embryos were transferred in 2023 with the rate of 59.5% positive pregnancies and 42.4% live births. This showcases our expertise in reproductive medicine and the ability to attract a diverse patient population seeking fertility solutions. Fortis (India) • Magnetic Resonance Linear Accelerator (MR LINAC): Combines MRI scan with radiation therapy, allowing for real-time visualisation of tumors during treatment. Patients benefit from more precise radiation delivery and fewer side effects, available at Fortis Memorial Research Institute Gurgaon (FMRI). • Gamma Knife: Non-invasive form of radiosurgery that delivers highly focused radiation to tumors in the brain. Patients benefit from precise tumor targeting and minimal damage to surrounding healthy tissue, available at FMRI. IHH Healthcare Malaysia • Actinium treatment: Targeted therapy for prostate cancer that delivers radiation directly to cancer cells while sparing surrounding tissues. Patients benefit from more effective treatment with fewer side effects. This is only offered at IHH hospitals in Malaysia. • CORI robotic system: Technology to assist surgeons during joint replacement surgeries, offering greater precision and accuracy. Patients benefit from smaller incisions, reduced pain, faster recovery, and improved long-term outcomes. Annual Report 2023 7
RkJQdWJsaXNoZXIy NDgzMzc=